#JITC Case Report: Allogenic Vγ9Vδ2 T cell as new potential immunotherapy drug for solid tumor: a case study for cholangiocarcinoma https://t.co/533SXS7LBh https://t.co/vYnQ6ThO3k
RT @sitcancer: #JITC Case Report: Allogenic Vγ9Vδ2 T cell as new potential immunotherapy drug for solid tumor: a case study for cholangioca…
RT @sitcancer: #JITC Case Report: Allogenic Vγ9Vδ2 T cell as new potential immunotherapy drug for solid tumor: a case study for cholangioca…
RT @sitcancer: #JITC Case Report: Allogenic Vγ9Vδ2 T cell as new potential immunotherapy drug for solid tumor: a case study for cholangioca…
RT @sitcancer: #JITC Case Report: Allogenic Vγ9Vδ2 T cell as new potential immunotherapy drug for solid tumor: a case study for cholangioca…
RT @sitcancer: #JITC Case Report: Allogenic Vγ9Vδ2 T cell as new potential immunotherapy drug for solid tumor: a case study for cholangioca…
#JITC Case Report: Allogenic Vγ9Vδ2 T cell as new potential immunotherapy drug for solid tumor: a case study for cholangiocarcinoma https://t.co/533SXS7LBh https://t.co/Lk9oa3TwGK
بداية رائعة للعام الجديد. قبول مقالتي الجديدة في مجله اكثر من رائعة. كل الشكر للمشرفين والزملاء والمشاركين و كل التوفيق للجميع ان شاء الله .و في الامس تم ظهورها اون لاين. لمن يريد الاطلاع عليها من الزملاء يمكن تنزيلها من الرابط.... https://t.co/YZEmfDAo60
RT @sitcancer: New #JITC Case Report: Allogenic Vγ9Vδ2 T cell as new potential immunotherapy drug for solid tumor: a case study for cholang…
RT @sitcancer: New #JITC Case Report: Allogenic Vγ9Vδ2 T cell as new potential immunotherapy drug for solid tumor: a case study for cholang…
Allogenic Vγ9Vδ2 T cell as new potential immunotherapy drug for solid tumor: a case study for cholangiocarcinoma https://t.co/3j3xBMuUIC
RT @sitcancer: New #JITC Case Report: Allogenic Vγ9Vδ2 T cell as new potential immunotherapy drug for solid tumor: a case study for cholang…
RT @sitcancer: New #JITC Case Report: Allogenic Vγ9Vδ2 T cell as new potential immunotherapy drug for solid tumor: a case study for cholang…
New #JITC Case Report: Allogenic Vγ9Vδ2 T cell as new potential immunotherapy drug for solid tumor: a case study for cholangiocarcinoma https://t.co/533SXS7LBh https://t.co/VUPxdQuzjl